Compumedics Limited (asx:cmp)business Update:sustainable, Profitable Performance




27th August 2010 -
Views: 1758
Leading Australia-based medical device company, Compumedics Limited (ASX: CMP), is pleased to announce a net profit after tax of $0.5 million on revenues of $32.4 million for the year ended 30 June, 2010.
U.s. Government Grants Awarded For Further Development Of Adult Stem Cell Products




8th November 2010 -
Views: 7278
Regenerative medicine company, Mesoblast Limited (ASX:MSB; USADR:MBLTY), today announced that its
United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United
States Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Australian Couples Give Birth To A Generation Free Of The Psychological Burden




26th October 2010 -
Views: 2571
Scientists call for wider awareness of Preimplantation Genetic Diagnosis for patients at high risk of passing breast cancer genes to their children.
Mesoblast Broadens Cancer Indications For Bone Marrow Transplant Product




14th October 2010 -
Views: 2529
Australian regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers.
Aussie Duo Breakthrough Weight Loss With Dna




13th October 2010 -
Views: 2889
Mr. Matt Patti, Australia’s Exercise Professional of the Year and Mr. Paul Beaver a
Doctor of Engineering are both long time devotees to finding the key to unlocking the
secrets to achieving sustained health, energy and vitality for women across
Australia.